Virtu Financial’s Bone Biologics BBLG Stock Holding History

Virtu Financial’s Portfolio BBLG Stock Details BBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-234	Closed	-$8K	–	1571
2023 Q3	$8K	Sell	234 -98	-30%	-$4.85K	﹤0.01%	1121
2023 Q2	$23K	Buy	+332	New	+$86.9K	﹤0.01%	1240
2023 Q1	–	Sell	-11	Closed	-$3K	–	1533
2022 Q4	$3K	Buy	+11	New	+$6.2K	﹤0.01%	1468

Other funds holding BBLG

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's BBLG Position: Q4 2023 in Review

Virtu Financial sold out of Bone Biologics (BBLG) in Q4 2023, closing a stake of 234 shares — an estimated $8K sold.

Virtu Financial first reported a position in BBLG in Q4 2022 and held it in 3 quarters. The position peaked at $23K in Q2 2023. 2 funds tracked by Wall St. Rank hold BBLG as of Q4 2023.

Virtu Financial reported no remaining Bone Biologics position as of Q4 2023 after selling out during the quarter.
Virtu Financial sold 234 Bone Biologics shares in Q4 2023, an estimated $8K.
Virtu Financial first reported a position in Bone Biologics in Q4 2022 and held it in 3 quarters.
Virtu Financial's Bone Biologics position peaked at $23K in Q2 2023.
2 funds tracked by Wall St. Rank held Bone Biologics as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.